Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 4:02 PM
Ignite Modification Date:
2025-12-25 @ 2:04 PM
NCT ID:
NCT00257166
Group ID:
EG000
Title:
Ziprasidone
Description:
Ziprasidone capsule administered orally in 2 divided doses daily in the morning and evening with a starting dose of ziprasidone 20 milligram per day (mg/day) as an evening dose on Day 1. This was followed by dose escalation of 20 mg/day every other day up to a target dose of ziprasidone 120 to 160 mg/day for participants with greater than or equal to \[\>=\] 45 kilogram \[kg\] weight and ziprasidone 60 to 80 mg/day for participants with less than \[\<\] 45 kg weight over 2 weeks, as per investigator's discretion. Flexible dosing of ziprasidone capsule 80 to 160 mg/day for participants with \>= 45 kg weight and ziprasidone capsule 40 to 80 mg/day for participants with \<45 kg weight orally in 2 divided doses daily in the morning and evening up to Week 4, as per investigator's discretion.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
6
Serious Number At Risk:
149
Other Number Affected:
128
Other Number At Risk:
149
Study:
NCT00257166
Results Section:
NCT00257166
Adverse Events Module:
NCT00257166